Stanford University infectious disease doctor Abraar Karan has seen a lot of patients with runny noses, fevers, and irritated eyes lately.
FDA approves Novartis’ Cosentyx
Novartis’ Cosentyx hinders interleukin-17A, a cytokine associated with inflammation in HS patients. Credit: Novartis AG. The US Food and Drug Administration (FDA) has granted approval for Novartis’
November 1, 2023